Pharmaceutical serialization and barcode requirements in Pakistan are regulated by the Drug Regulatory Authority of Pakistan (DRAP). Pakistan has established a regulatory framework requiring barcode identification on pharmaceutical packaging and is progressing toward the implementation of serialization for medicines.
The regulatory foundation is defined under S.R.O. 470(I)/2017 – Drugs Labelling and Packing Rules, which introduced mandatory barcode labeling for pharmaceutical products to support identification, tracking, and verification within the supply chain.
Pakistan is currently transitioning from basic barcode identification to GS1 DataMatrix based serialization. Regulatory updates issued by DRAP indicate that the authority is moving toward the implementation of 2D barcodes with serialized identifiers on pharmaceutical packaging.
At present, Pakistan’s framework focuses primarily on product identification through barcodes and serialization readiness, and a fully operational national end to end track and trace reporting platform has not yet been publicly implemented.